Patent details

Basic Information

Publication number:

EP3482770

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP182143966

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNOGENIC COMPOSITIONS

French Title of Invention:

COMPOSITIONS IMMUNOGÈNES

German Title of Invention:

IMMUNOGENE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

03/10/2013

Grant date:

25/11/2020

EP Publication Date:

15/05/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/11/2020

EP B1 Publication Date:

25/11/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2021

Expiration date:

03/10/2033

Renunciation date:

Revocation date:

19/08/2025

Annulment date:

Owner

From:

18/11/2020

 

 

Name:

GlaxoSmithKline Biologicals S.A.

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:

GRANDI, Guido

Address:

Italy (IT)

2

Name:

MARGARIT Y ROS, Immaculada

Address:

Italy (IT)

3

Name:

MAIONE, Domenico

Address:

Italy (IT)

Priority

1

Priority Number:

201261744880 P

Priority Date:

03/10/2012

Priority Country:

United States (US)

2

Priority Number:

201361799123 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/09;

Publication

European Patent Bulletin

1

Issue number:

202048

Publication date:

25/11/2020

Description:

Grant (B1)

2

Issue number:

202543

Publication date:

22/10/2025

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages